FEDERATED HERMES, INC. - FUSION PHARMACEUTICALS INC ownership

FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 52 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of FUSION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$27,777,851
-44.2%
10,683,789
+0.5%
0.07%
-40.3%
Q2 2023$49,766,133
+125.7%
10,633,789
+81.8%
0.12%
+125.5%
Q1 2023$22,051,107
+117.1%
5,849,100
+81.4%
0.06%
+96.4%
Q4 2022$10,155,915
+6.3%
3,224,100
+1.6%
0.03%0.0%
Q3 2022$9,555,000
+22.8%
3,174,100
+1.6%
0.03%
+33.3%
Q2 2022$7,779,000
-67.2%
3,124,100
+2.3%
0.02%
-61.1%
Q1 2022$23,738,000
+261.6%
3,055,037
+94.1%
0.05%
+350.0%
Q4 2021$6,564,000
-43.0%
1,574,000
+8.3%
0.01%
-45.5%
Q3 2021$11,514,000
+138.4%
1,453,890
+143.2%
0.02%
+144.4%
Q2 2021$4,830,000
-20.3%
597,841
+5.8%
0.01%
-25.0%
Q1 2021$6,057,000
-1.8%
565,000
+7.6%
0.01%
-7.7%
Q4 2020$6,169,000
+0.6%
525,000
+2.9%
0.01%
-7.1%
Q3 2020$6,130,000
+9.7%
510,000
+59.4%
0.01%0.0%
Q2 2020$5,590,000320,0000.01%
Other shareholders
FUSION PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 2,973,744$24,028,0004.99%
Pivotal bioVenture Partners Investment Advisor LLC 1,598,377$12,613,0004.97%
Johnson & Johnson Innovation - JJDC, Inc. 3,670,516$29,658,0003.03%
Sio Capital Management, LLC 266,107$2,150,0000.53%
Orbimed Advisors 3,224,770$26,056,0000.26%
Perceptive Advisors 3,550,334$28,686,0000.19%
AlphaCentric Advisors LLC 71,500$578,0000.16%
Rock Springs Capital Management LP 948,327$7,662,0000.15%
TPG Group Holdings (SBS) Advisors, Inc. 2,551,794$20,618,0000.15%
Artal Group S.A. 750,000$6,060,0000.12%
View complete list of FUSION PHARMACEUTICALS INC shareholders